Bellevue Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-15
Closed -$1K 499
2022
Q3
$1K Hold
15
﹤0.01% 493
2022
Q2
$1K Hold
15
﹤0.01% 496
2022
Q1
$1K Sell
15
-3
-17% -$200 ﹤0.01% 531
2021
Q4
$3K Sell
18
-1
-5% -$167 ﹤0.01% 466
2021
Q3
$3K Hold
19
﹤0.01% 488
2021
Q2
$3K Buy
19
+8
+73% +$1.26K ﹤0.01% 486
2021
Q1
$2K Buy
+11
New +$2K ﹤0.01% 609